We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Arista Networks
ANET
$214B
| $247K | 0.12% |
+1,883
| New | +$259K |
|
402
SEI Investments
SEIC
$12.4B
| $247K | 0.12% |
3,008
+309
| +11% | +$25.4K |
|
403
Coursera
COUR
$1.68B
| $245K | 0.12% |
33,353
+10,135
| +44% | +$88.3K |
|
404
Citi Trends
CTRN
$559M
| $245K | 0.12% |
+5,904
| New | +$233K |
|
|
B
405
Barrick Mining
B
$61.5B
| $245K | 0.12% |
+5,627
| New | +$211K |
|
|
GAP
406
The Gap Inc
GAP
$7.28B
| $245K | 0.12% |
+9,572
| New | +$232K |
|
407
Loews
L
$24.6B
| $245K | 0.12% |
+2,326
| New | +$240K |
|
408
Watts Water Technologies
WTS
$11.6B
| $244K | 0.12% |
+885
| New | +$244K |
|
409
Ciena
CIEN
$49.6B
| $244K | 0.12% |
1,044
-510
| -33% | -$98.9K |
|
410
Kanzhun
BZ
$7.07B
| $244K | 0.12% |
11,970
-2,473
| -17% | -$53.4K |
|
411
CleanSpark
CLSK
$3.46B
| $243K | 0.12% |
+24,027
| New | +$360K |
|
412
Bankunited
BKU
$3.41B
| $243K | 0.12% |
5,454
-226
| -4% | -$9.36K |
|
413
Shake Shack
SHAK
$2.55B
| $243K | 0.12% |
2,993
-1,937
| -39% | -$171K |
|
414
Verra Mobility
VRRM
$635M
| $243K | 0.12% |
+10,834
| New | +$247K |
|
415
Progressive
PGR
$128B
| $242K | 0.12% |
1,061
-257
| -19% | -$58K |
|
|
UHT
416
Universal Health Realty Income Trust
UHT
$627M
| $242K | 0.12% |
+6,161
| New | +$240K |
|
417
Mercury Insurance
MCY
$6.07B
| $242K | 0.12% |
2,568
-1,422
| -36% | -$123K |
|
|
TIGR
418
UP Fintech Holding
TIGR
$858M
| $241K | 0.12% |
25,260
-43,499
| -63% | -$415K |
|
|
AL
419
DELISTED
Air Lease Corp
AL
| $241K | 0.12% |
+3,755
| New | +$240K |
|
420
GXO Logistics
GXO
$6.13B
| $241K | 0.12% |
+4,579
| New | +$241K |
|
421
KBR
KBR
$4.74B
| $241K | 0.12% |
+5,996
| New | +$257K |
|
422
Quest Diagnostics
DGX
$26B
| $241K | 0.12% |
+1,386
| New | +$252K |
|
423
WEX
WEX
$6.23B
| $240K | 0.12% |
+1,608
| New | +$242K |
|
424
Ascendis Pharma A/S
ASND
$16.7B
| $239K | 0.12% |
1,122
-48
| -4% | -$9.91K |
|
425
American States Water
AWR
$3.45B
| $239K | 0.12% |
3,300
-2,547
| -44% | -$187K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.